XML 37 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
Loss Before Income Tax - Summary of Loss Before Income Tax (Details) - USD ($)
$ in Thousands
 3 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Revenue    
Commercialization revenue $ 1,443 $ 2,422
Milestone revenue   1,172
Interest revenue 60  
Total Revenue 1,503 3,594
Clinical trial and research & development (658) (2,583)
Manufacturing production & development (5,376) (7,918)
Employee benefits    
Salaries and employee benefits (4,704) (5,452)
Defined contribution superannuation expenses (84) (96)
Equity settled share-based payment transactions (350) (1,076)
Total Employee benefits 5,138 6,624
Depreciation and amortization of non-current assets    
Plant and equipment depreciation (296) (290)
Right of use asset depreciation (432) (410)
Intellectual property amortization (377) (393)
Total Depreciation and amortization of non-current assets (1,105) (1,093)
Other Management & administration expenses    
Overheads & administration (2,537) (2,098)
Consultancy (1,329) (773)
Legal, patent and other professional fees (802) (1,033)
Intellectual property expenses (excluding the amount amortized above) (563) (621)
Total Other Management & administration expenses (5,231) (4,525)
Fair value remeasurement of contingent consideration    
Remeasurement of contingent consideration 4,468 280
Total Fair value remeasurement of contingent consideration 4,468 280
Fair value remeasurement of warrant liability    
Remeasurement of warrant liability (401)  
Total Fair value remeasurement of warrant liability (401)  
Other operating income and expenses    
Foreign exchange (losses) (504) (119)
Foreign withholding tax paid   (59)
Total Other operating income and expenses (504) (178)
Finance (costs)/gains    
Remeasurement of borrowing arrangements 54 480
Interest expense (4,551) (4,140)
Total Finance costs (4,497) (3,660)
Loss before income tax $ (16,939) $ (22,707)